Travere Therapeutics Provides Corporate Update and 2026 Outlook View Full Press Release Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)